Guidepost

Guidepost is a South African healthtech startup founded in 2012, focusing on personalized diabetes management through telemedicine. The company offers a data-driven platform that enables individuals to better manage their diabetes risk, achieving a 45% reduction in diabetes complications across over 8,000 patients in six years. Guidepost collaborates with life insurers, medical schemes, and pharmaceutical companies to enhance diabetes care. In August 2020, Guidepost secured an undisclosed amount of funding from AlphaCode, the fintech investment arm of Rand Merchant Investment Holdings, acquiring a 25.1% stake in the company. This investment aimed to support Guidepost's expansion both domestically and internationally. The funds were intended to develop Guidepost's clinical technology and broaden its reach in the healthcare sector. Guidepost's platform connects patients with a network of diabetes coaches, providing personalized support to help individuals achieve life-changing health outcomes. The company's innovative approach has positioned it as a significant player in the healthtech industry, addressing the challenges of diabetes management through technology-driven solutions.

Focus on healthtech and insurtech sectors, Interest in early-stage technology companies, Alignment with Guidepost's mission to improve diabetes care